about
Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining f...
Read More
10.72
-0.19
(-1.74%)
7.4M
XNAS Volume
XNAS 14 Nov, 2025 4:30 PM (EST)
Low Financial Strength
Mid Valuation
Technically Moderately Bullish
Momentum Trap
These stocks are with bad quality but mid-range Valuation. However, their good technical scoring may generate some interest amongst the audience.
View Similar
Embed DVM
Viatris Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..